|
[1]
|
Qu, X. and Shi, Y. (2022) Bile Reflux and Bile Acids in the Progression of Gastric Intestinal Metaplasia. Chinese Medical Journal, 135, 1664-1672. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
He, Q., Liu, L., Wei, J., Jiang, J., Rong, Z., Chen, X., et al. (2022) Roles and Action Mechanisms of Bile Acid-Induced Gastric Intestinal Metaplasia: A Review. Cell Death Discovery, 8, Article No. 158. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Kim, Y.S., Unno, T., Park, S., Chung, J.O., Choi, Y., Lee, S., et al. (2024) Effect of Bile Reflux on Gastric Juice Microbiota in Patients with Different Histology Phenotypes. Gut Pathogens, 16, Article No. 26. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Lee, S., Park, M., Park, S., Choi, Y., Chung, J., Kim, D., et al. (2022) Primary Bile Acid Activates Egr-1 Expression through the MAPK Signaling Pathway in Gastric Cancer. Molecular Medicine Reports, 25, Article No. 129. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
El-Omar, E.M., Carrington, M., Chow, W., McColl, K.E.L., Bream, J.H., Young, H.A., et al. (2000) Interleukin-1 Polymorphisms Associated with Increased Risk of Gastric Cancer. Nature, 404, 398-402. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Camargo, M.C., Mera, R., Correa, P., Peek, R.M., Fontham, E.T.H., Goodman, K.J., et al. (2006) Interleukin-1β and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Gastric Cancer: A Meta-Analysis. Cancer Epidemiology, Biomarkers & Prevention, 15, 1674-1687. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Durães, C., Muñoz, X., Bonet, C., García, N., Venceslá, A., Carneiro, F., et al. (2014) Genetic Variants in the IL1A Gene Region Contribute to Intestinal‐Type Gastric Carcinoma Susceptibility in European Populations. International Journal of Cancer, 135, 1343-1355. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Osei-Sarfo, K. and Gudas, L.J. (2014) Retinoic Acid Suppresses the Canonical Wnt Signaling Pathway in Embryonic Stem Cells and Activates the Noncanonical Wnt Signaling Pathway. Stem Cells, 32, 2061-2071. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Bouriez, D., Giraud, J., Gronnier, C. and Varon, C. (2018) Efficiency of All-Trans Retinoic Acid on Gastric Cancer: A Narrative Literature Review. International Journal of Molecular Sciences, 19, Article 3388. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Mezquita, B. and Mezquita, C. (2019) Two Opposing Faces of Retinoic Acid: Induction of Stemness or Induction of Differentiation Depending on Cell-Type. Biomolecules, 9, Article 567. [Google Scholar] [CrossRef]
|
|
[11]
|
Yao, W., Wang, L., Huang, H., Li, X., Wang, P., Mi, K., et al. (2020) All-Trans Retinoic Acid Reduces Cancer Stem Cell-Like Cell-Mediated Resistance to Gefitinib in NSCLC Adenocarcinoma Cells. BMC Cancer, 20, Article No. 315. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Modarai, S.R., Gupta, A., Opdenaker, L.M., Kowash, R., Masters, G., Viswanathan, V., et al. (2018) The Anti-Cancer Effect of Retinoic Acid Signaling in CRC Occurs via Decreased Growth of ALDH+ Colon Cancer Stem Cells and Increased Differentiation of Stem Cells. Oncotarget, 9, 34658-34669. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Brown, G. (2023) Targeting the Retinoic Acid Pathway to Eradicate Cancer Stem Cells. International Journal of Molecular Sciences, 24, 2373. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Lavudi, K., Nuguri, S.M., Olverson, Z., Dhanabalan, A.K., Patnaik, S. and Kokkanti, R.R. (2023) Targeting the Retinoic Acid Signaling Pathway as a Modern Precision Therapy against Cancers. Frontiers in Cell and Developmental Biology, 11, Article ID: 1254612. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Jin, D., Huang, K., Xu, M., Hua, H., Ye, F., Yan, J., et al. (2022) Deoxycholic Acid Induces Gastric Intestinal Metaplasia by Activating STAT3 Signaling and Disturbing Gastric Bile Acids Metabolism and Microbiota. Gut Microbes, 14, Article 2120744. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Yu, J., Zheng, J., Qi, J., Yang, K., Wu, Y., Wang, K., et al. (2019) Bile Acids Promote Gastric Intestinal Metaplasia by Upregulating CDX2 and MUC2 Expression via the FXR/NF-κB Signalling Pathway. International Journal of Oncology, 54, 879-892. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Zhang, M., Zhong, J., Shen, Y. and Song, Z. (2025) Crosstalk between Bile Acids and Gut Microbiota: A Potential Target for Precancerous Lesions of Gastric Cancer. Frontiers in Pharmacology, 16, Article ID: 1533141. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Posteraro, B., Persiani, R., Dall’Armi, V., Biondi, A., Arzani, D., Sicoli, F., et al. (2014) Prognostic Factors and Outcomes in Italian Patients Undergoing Curative Gastric Cancer Surgery. European Journal of Surgical Oncology (EJSO), 40, 345-351. [Google Scholar] [CrossRef] [PubMed]
|